Stay updated with breaking news from Tau Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Truist Financial began coverage on shares of Voyager Therapeutics (NASDAQ:VYGR – Get Rating) in a research note published on Wednesday morning, The Fly reports. The firm issued a buy rating and a $18.00 target price on the stock. VYGR has been the subject of several other research reports. StockNews.com cut shares of Voyager Therapeutics from […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) – Analysts at Wedbush issued their Q1 2024 earnings per share estimates for Voyager Therapeutics in a research report issued on Tuesday, May 9th. Wedbush analyst L. Chico forecasts that the company will post earnings per share of ($0.67) for the quarter. The consensus estimate for Voyager Therapeutics’ […]
StockNews.com upgraded shares of Voyager Therapeutics (NASDAQ:VYGR – Get Rating) from a hold rating to a buy rating in a research report sent to investors on Thursday. Other analysts have also issued research reports about the stock. Truist Financial assumed coverage on shares of Voyager Therapeutics in a research note on Wednesday. They set a […]
C4 Therapeutics (NASDAQ:CCCC – Get Rating) and Voyager Therapeutics (NASDAQ:VYGR – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Institutional and Insider Ownership 80.3% of C4 Therapeutics shares […]
C4 Therapeutics (NASDAQ:CCCC – Get Rating) and Voyager Therapeutics (NASDAQ:VYGR – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends. Earnings & Valuation This table compares C4 Therapeutics and […]